{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:37:20Z","timestamp":1790127440200,"version":"4.0.1"},"reference-count":47,"publisher":"Becaris Publishing Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Comp. Eff. Res."],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:p>\n            <jats:bold>Aim:<\/jats:bold>\n            Determine the effectiveness of hypothermically stored amniotic membrane (HSAM) versus standard of care (SOC) in diabetic foot ulcers (DFUs).\n            <jats:bold>Methods:<\/jats:bold>\n            A randomized controlled trial was conducted on 76 DFUs analyzed digitally.\n            <jats:bold>Results:<\/jats:bold>\n            Cox wound closure for HSAM (38 wounds) was significantly greater (p = 0.04) at weeks 12 (60 vs 38%), and 16 (63 vs 38%). The probability of wound closure increased by 75% (Hazard Ratio = 1.75; 95% CI: 1.16\u20132.70). HSAM showed &gt;60% reductions in area (82 vs 58%; p = 0.02) and depth (65 vs 39%; p = 0.04) versus SOC.\n            <jats:bold>Conclusion:<\/jats:bold>\n            HSAM increased frequency and probability of wound closure in DFUs versus SOC.\n          <\/jats:p>","DOI":"10.2217\/cer-2019-0142","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T12:56:31Z","timestamp":1573044991000},"page":"23-34","source":"Crossref","is-referenced-by-count":47,"title":["A randomized controlled clinical trial of a hypothermically stored amniotic membrane for use in diabetic foot ulcers"],"prefix":"10.57264","volume":"9","author":[{"given":"Thomas E","family":"Serena","sequence":"first","affiliation":[{"name":"SerenaGroup\u00ae Research Foundation, Cambridge, MA 02140, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Yaakov","sequence":"additional","affiliation":[{"name":"SerenaGroup\u00ae Research Foundation, Cambridge, MA 02140, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Moore","sequence":"additional","affiliation":[{"name":"SerenaGroup\u00ae Research Foundation, Cambridge, MA 02140, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Windy","family":"Cole","sequence":"additional","affiliation":[{"name":"Kent State University College of Podiatric Medicine, Independence, OH 44131, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Coe","sequence":"additional","affiliation":[{"name":"Kent State University College of Podiatric Medicine, Independence, OH 44131, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Snyder","sequence":"additional","affiliation":[{"name":"Barry University School of Podiatry Medicine, North Miami Beach, FL 33168, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyur","family":"Patel","sequence":"additional","affiliation":[{"name":"D &amp; P Medical Group, Pittsburgh, PA 15237, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Doner","sequence":"additional","affiliation":[{"name":"D &amp; P Medical Group, Pittsburgh, PA 15237, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A","family":"Kasper","sequence":"additional","affiliation":[{"name":"Martin Foot &amp; Ankle, York, PA 17402, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Hamil","sequence":"additional","affiliation":[{"name":"SerenaGroup\u00ae Research Foundation, Cambridge, MA 02140, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santina","family":"Wendling","sequence":"additional","affiliation":[{"name":"Organogenenis, Inc, Canton, MA 02021, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7834-9040","authenticated-orcid":false,"given":"Michael L","family":"Sabolinski","sequence":"additional","affiliation":[{"name":"Sabolinski LLC, Franklin, MA 02038, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"36897","reference":[{"issue":"4","key":"e_1_3_7_2_2","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2337\/dc12-2625","article-title":"Economic costs of diabetes in the U.S. in 2012","volume":"36","author":"American Diabetes Association AD","year":"2013","unstructured":"American Diabetes Association AD. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 36(4), 1033\u20131046 (2013).","journal-title":"Diabetes Care"},{"issue":"2","key":"e_1_3_7_3_2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jama.293.2.217","article-title":"Preventing foot ulcers in patients with diabetes","volume":"293","author":"Singh N","year":"2005","unstructured":"Singh N , Armstrong DG , Lipsky BA . Preventing foot ulcers in patients with diabetes. JAMA 293(2), 217 (2005).","journal-title":"JAMA"},{"issue":"6","key":"e_1_3_7_4_2","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2337\/diacare.26.6.1879","article-title":"Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial","volume":"26","author":"Sheehan P","year":"2003","unstructured":"Sheehan P , Jones P , Caselli A , Giurini JM , Veves A . Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes care. 26(6), 1879\u2013 1882 (2003).","journal-title":"Diabetes care"},{"issue":"6","key":"e_1_3_7_5_2","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.2337\/diacare.26.6.1696","article-title":"Surrogate end points for the treatment of diabetic neuropathic foot ulcers","volume":"26","author":"Margolis DJ","year":"2003","unstructured":"Margolis DJ , Gelfand JM , Hoffstad O , Berlin JA . Surrogate end points for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 26(6), 1696\u20131700 (2003).","journal-title":"Diabetes Care"},{"issue":"3","key":"e_1_3_7_6_2","first-page":"44","article-title":"A post-hoc analysis of reduction in diabetic foot ulcer size at 4 weeks as a predictor of healing by 12 weeks","volume":"56","author":"Snyder RJ","year":"2010","unstructured":"Snyder RJ , Cardinal M , Dauphin\u00e9e DM , Stavosky J . A post-hoc analysis of reduction in diabetic foot ulcer size at 4 weeks as a predictor of healing by 12 weeks. Ostomy. Wound. Manage. 56(3), 44\u201350 (2010).","journal-title":"Ostomy. Wound. Manage."},{"issue":"9","key":"e_1_3_7_7_2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/wound.2015.0635","article-title":"Challenges in the treatment of chronic wounds","volume":"4","author":"Frykberg RG","year":"2015","unstructured":"Frykberg RG , Banks J . Challenges in the treatment of chronic wounds. Adv. Wound Care 4(9), 560\u2013582 (2015).","journal-title":"Adv. Wound Care"},{"issue":"3","key":"e_1_3_7_8_2","doi-asserted-by":"crossref","first-page":"17S","DOI":"10.1016\/j.jvs.2010.06.003","article-title":"The costs of diabetic foot: the economic case for the limb salvage team","volume":"52","author":"Driver VR","year":"2010","unstructured":"Driver VR , Fabbi M , Lavery LA , Gibbons G . The costs of diabetic foot: the economic case for the limb salvage team. J. Vasc. Surg. 52(3), 17S\u201322S (2010).","journal-title":"J. Vasc. Surg."},{"issue":"13","key":"e_1_3_7_9_2","first-page":"58","article-title":"Prevalence of diabetic foot and the associated risk factors at primary health care level in southwestern Saudi Arabia","volume":"5","author":"Al-Musa HM","year":"2013","unstructured":"Al-Musa HM . Prevalence of diabetic foot and the associated risk factors at primary health care level in southwestern Saudi Arabia Int. J. Current Research & Rev. 5(13), 58 (2013).","journal-title":"Int. J. Current Research & Rev."},{"issue":"11","key":"e_1_3_7_10_2","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1242\/dmm.016782","article-title":"Clinical challenges of chronic wounds: searching for an optimal animal model to recapitulate their complexity","volume":"7","author":"Nunan R","year":"2014","unstructured":"Nunan R , Harding KG , Martin P . Clinical challenges of chronic wounds: searching for an optimal animal model to recapitulate their complexity. Dis. Model. Mech. 7(11), 1205\u20131213 (2014).","journal-title":"Dis. Model. Mech."},{"issue":"1","key":"e_1_3_7_11_2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12902-016-0111-0","article-title":"Reducing major lower extremity amputations after the introduction of a multidisciplinary team in patient with diabetes foot ulcer","volume":"16","author":"Wang C","year":"2016","unstructured":"Wang C , Mai L , Yang C Reducing major lower extremity amputations after the introduction of a multidisciplinary team in patient with diabetes foot ulcer. BMC Endocr. Disord. 16(1), 38 (2016).","journal-title":"BMC Endocr. Disord."},{"key":"e_1_3_7_12_2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2147\/CWCMR.S85463","article-title":"Preventing, minimizing, and managing pain in patients with chronic wounds: challenges and solutions","volume":"3","author":"Serena T","year":"2016","unstructured":"Serena T , Yaakov R , Aslam S , Aslam R . Preventing, minimizing, and managing pain in patients with chronic wounds: challenges and solutions. Chronic Wound Care Manag. Res. 3, 85\u201390 (2016).","journal-title":"Chronic Wound Care Manag. Res."},{"issue":"4","key":"e_1_3_7_13_2","article-title":"The impact of diabetic foot ulcer pain on patient quality of life","volume":"7","author":"Bradbury S","year":"2011","unstructured":"Bradbury S , Price P . The impact of diabetic foot ulcer pain on patient quality of life. Wounds UK 7(4), (2011).","journal-title":"Wounds UK"},{"issue":"6","key":"e_1_3_7_14_2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/iwj.12782","article-title":"Differences in the daily activity of patients with diabetic foot ulcers compared to controls in their free-living environments","volume":"14","author":"Sheahan H","year":"2017","unstructured":"Sheahan H , Canning K , Refausse N Differences in the daily activity of patients with diabetic foot ulcers compared to controls in their free-living environments. Int. Wound J. 14(6), 1175\u20131182 (2017).","journal-title":"Int. Wound J."},{"key":"e_1_3_7_15_2","doi-asserted-by":"crossref","first-page":"435487","DOI":"10.6064\/2012\/435487","article-title":"Contemporary evaluation and management of the diabetic foot","volume":"2012","author":"Sumpio BE","year":"2012","unstructured":"Sumpio BE . Contemporary evaluation and management of the diabetic foot. Scientifica. 2012, 435487 (2012).","journal-title":"Scientifica."},{"issue":"6","key":"e_1_3_7_16_2","first-page":"30","article-title":"A retrospective review of adverse events related to diabetic foot ulcers","volume":"63","author":"Allen L","year":"2017","unstructured":"Allen L , Powell-Cope G , Mbah A , Bulat T , Njoh E . A retrospective review of adverse events related to diabetic foot ulcers. Ostomy. Wound. Manage. 63(6), 30\u201333 (2017).","journal-title":"Ostomy. Wound. Manage."},{"issue":"1","key":"e_1_3_7_17_2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/wrr.12384","article-title":"Rapid identification of slow healing wounds","volume":"24","author":"Jung K","year":"2016","unstructured":"Jung K , Covington S , Sen CK Rapid identification of slow healing wounds. Wound Repair Regen. 24(1), 181\u2013188 (2016).","journal-title":"Wound Repair Regen."},{"issue":"3","key":"e_1_3_7_18_2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2337\/dc13-2176","article-title":"Burden of diabetic foot ulcers for medicare and private insurers","volume":"37","author":"Rice JB","year":"2014","unstructured":"Rice JB , Desai U , Cummings AKG , Birnbaum HG , Skornicki M , Parsons NB . Burden of diabetic foot ulcers for medicare and private insurers. Diabetes Care 37(3), 651\u2013658 (2014).","journal-title":"Diabetes Care"},{"issue":"8","key":"e_1_3_7_19_2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3111\/13696998.2015.1031793","article-title":"Economic outcomes among Medicare patients receiving bioengineered cellular technologies for treatment of diabetic foot ulcers","volume":"18","author":"Rice JB","year":"2015","unstructured":"Rice JB , Desai U , Ristovska L Economic outcomes among Medicare patients receiving bioengineered cellular technologies for treatment of diabetic foot ulcers. J. Med. Econ. 18(8), 586\u2013595 (2015).","journal-title":"J. Med. Econ."},{"issue":"1","key":"e_1_3_7_20_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jval.2017.07.007","article-title":"An economic evaluation of the impact, cost, and Medicare policy implications of chronic nonhealing wounds","volume":"21","author":"Nussbaum SR","year":"2018","unstructured":"Nussbaum SR , Carter MJ , Fife CE An economic evaluation of the impact, cost, and Medicare policy implications of chronic nonhealing wounds. Value Health 21(1), 27\u201332 (2018).","journal-title":"Value Health"},{"issue":"5","key":"e_1_3_7_21_2","doi-asserted-by":"crossref","first-page":"e0177916","DOI":"10.1371\/journal.pone.0177916","article-title":"Incidence and risk factors for developing infection in patients presenting with uninfected diabetic foot ulcers","volume":"12","author":"Jia L","year":"2017","unstructured":"Jia L , Parker CN , Parker TJ Incidence and risk factors for developing infection in patients presenting with uninfected diabetic foot ulcers. PLoS ONE 12(5), e0177916 (2017).","journal-title":"PLoS ONE"},{"issue":"4","key":"e_1_3_7_22_2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4239\/wjd.v8.i4.135","article-title":"Osteomyelitis in diabetic foot: a comprehensive overview","volume":"8","author":"Giurato L","year":"2017","unstructured":"Giurato L , Meloni M , Izzo V , Uccioli L . Osteomyelitis in diabetic foot: a comprehensive overview. World J. Diabetes 8(4), 135 (2017).","journal-title":"World J. Diabetes"},{"key":"e_1_3_7_23_2","doi-asserted-by":"crossref","first-page":"5941957","DOI":"10.1155\/2016\/5941957","article-title":"Prevalence and risk factors for diabetic lower limb amputation: a clinic-based case control study","volume":"2016","author":"Rodrigues BT","year":"2016","unstructured":"Rodrigues BT , Vangaveti VN , Malabu UH . Prevalence and risk factors for diabetic lower limb amputation: a clinic-based case control study. J. Diabetes Res. 2016, 5941957 (2016).","journal-title":"J. Diabetes Res."},{"issue":"5","key":"e_1_3_7_24_2","first-page":"375","article-title":"Clinical and cost efficacy of advanced wound care matrices for venous ulcers","volume":"18","author":"Hankin CS","year":"2012","unstructured":"Hankin CS , Knispel J , Lopes M , Bronstone A , Maus E . Clinical and cost efficacy of advanced wound care matrices for venous ulcers. J. Manag. Care Pharm. 18(5), 375\u2013384 (2012).","journal-title":"J. Manag. Care Pharm."},{"issue":"5","key":"e_1_3_7_25_2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/wrr.12332","article-title":"Comparative effectiveness of a bioengineered living cellular construct vs. a dehydrated human amniotic membrane allograft for the treatment of diabetic foot ulcers in a real world setting","volume":"23","author":"Kirsner RS","year":"2015","unstructured":"Kirsner RS , Sabolinski ML , Parsons NB , Skornicki M , Marston WA . Comparative effectiveness of a bioengineered living cellular construct vs. a dehydrated human amniotic membrane allograft for the treatment of diabetic foot ulcers in a real world setting. Wound Repair Regen. 23(5), 737\u2013744 (2015).","journal-title":"Wound Repair Regen."},{"issue":"5","key":"e_1_3_7_26_2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/iwj.12329","article-title":"The efficacy and safety of Grafix\u00ae for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial","volume":"11","author":"Lavery LA","year":"2014","unstructured":"Lavery LA , Fulmer J , Shebetka KA The efficacy and safety of Grafix\u00ae for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial. Int. Wound J. 11(5), 554\u2013560 (2014).","journal-title":"Int. Wound J."},{"issue":"5","key":"e_1_3_7_27_2","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s13300-017-0298-8","article-title":"Efficacy and time sensitivity of amniotic membrane treatment in patients with diabetic foot ulcers: a systematic review and meta-analysis","volume":"8","author":"Laurent I","year":"2017","unstructured":"Laurent I , Ast\u00e8re M , Wang KR , Cheng Q , Li QF . Efficacy and time sensitivity of amniotic membrane treatment in patients with diabetic foot ulcers: a systematic review and meta-analysis. Diabetes Ther. 8(5), 967\u2013979 (2017).","journal-title":"Diabetes Ther."},{"issue":"7","key":"e_1_3_7_28_2","first-page":"248","article-title":"Comparison of a bioimplant dressing with a wet dressing for the treatment of diabetic foot ulcers: a randomized, controlled clinical trial","volume":"28","author":"Mohajeri-Tehrani MR","year":"2016","unstructured":"Mohajeri-Tehrani MR , Variji Z , Mohseni S Comparison of a bioimplant dressing with a wet dressing for the treatment of diabetic foot ulcers: a randomized, controlled clinical trial. Wounds 28(7), 248\u2013254 (2016).","journal-title":"Wounds"},{"issue":"2","key":"e_1_3_7_29_2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/wrr.12635","article-title":"Effectiveness of viable cryopreserved placental membranes for management of diabetic foot ulcers in a real world setting","volume":"26","author":"Raspovic KM","year":"2018","unstructured":"Raspovic KM , Wukich DK , Naiman DQ Effectiveness of viable cryopreserved placental membranes for management of diabetic foot ulcers in a real world setting. Wound Repair Regen. 26(2), 213\u2013220 (2018).","journal-title":"Wound Repair Regen."},{"issue":"6","key":"e_1_3_7_30_2","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/iwj.12748","article-title":"In vitro assessment of a novel, hypothermically stored amniotic membrane for use in a chronic wound environment","volume":"14","author":"McQuilling JP","year":"2017","unstructured":"McQuilling JP , Vines JB , Mowry KC . In vitro assessment of a novel, hypothermically stored amniotic membrane for use in a chronic wound environment . Int. Wound J. 14(6), 993\u20131005 (2017).","journal-title":"Int. Wound J."},{"issue":"5","key":"e_1_3_7_31_2","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/jbm.b.33265","article-title":"Cytokines in single layer amnion allografts compared to multilayer amnion\/chorion allografts for wound healing","volume":"103","author":"Koob TJ","year":"2015","unstructured":"Koob TJ , Lim JJ , Zabek N , Massee M . Cytokines in single layer amnion allografts compared to multilayer amnion\/chorion allografts for wound healing. J. Biomed. Mater. Res. Part B Appl. Biomater. 103(5), 1133\u20131140 (2015).","journal-title":"J. Biomed. Mater. Res. Part B Appl. Biomater."},{"issue":"5","key":"e_1_3_7_32_2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.ASW.0000482354.01988.b4","article-title":"Components and quality measures of DIME (devitalized tissue, infection\/inflammation, moisture balance, and edge preparation) in wound care","volume":"29","author":"Snyder RJ","year":"2016","unstructured":"Snyder RJ , Fife C , Moore Z . Components and quality measures of DIME (devitalized tissue, infection\/inflammation, moisture balance, and edge preparation) in wound care. Adv. Skin Wound Care 29(5), 205\u2013215 (2016).","journal-title":"Adv. Skin Wound Care"},{"issue":"5","key":"e_1_3_7_33_2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/iwj.12328","article-title":"Validation of a laser-assisted wound measurement device in a wound healing model","volume":"13","author":"Constantine RS","year":"2016","unstructured":"Constantine RS , Bills JD , Lavery LA , Davis KE . Validation of a laser-assisted wound measurement device in a wound healing model. Int. Wound J. 13(5), 614\u2013618 (2016).","journal-title":"Int. Wound J."},{"key":"e_1_3_7_34_2","unstructured":"ARANZ Medical. ARANZ medical resources (2019). www.aranzmedical.com\/aranz-medical-resources\/."},{"issue":"5","key":"e_1_3_7_35_2","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1177\/193229681300700508","article-title":"Validation of a laser-assisted wound measurement device for measuring wound volume","volume":"7","author":"Davis KE","year":"2013","unstructured":"Davis KE , Constantine FC , MacAslan EC , Bills JD , Noble DL , Lavery LA . Validation of a laser-assisted wound measurement device for measuring wound volume. J. Diabetes Sci. Technol. 7(5), 1161\u20131166 (2013).","journal-title":"J. Diabetes Sci. Technol."},{"issue":"2","key":"e_1_3_7_36_2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2337\/diacare.24.2.290","article-title":"Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial","volume":"24","author":"Veves A","year":"2001","unstructured":"Veves A , Falanga V , Armstrong DG , Sabolinski ML . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care. 24(2), 290\u2013295 (2001).","journal-title":"Diabetes Care."},{"issue":"5","key":"e_1_3_7_37_2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/wrr.12332","article-title":"Comparative effectiveness of a bioengineered living cellular construct vs. a dehydrated human amniotic membrane allograft for the treatment of diabetic foot ulcers in a real world setting","volume":"23","author":"Kirsner RS","year":"2015","unstructured":"Kirsner RS , Sabolinski ML , Parsons NB , Skornicki M , Marston WA . Comparative effectiveness of a bioengineered living cellular construct vs. a dehydrated human amniotic membrane allograft for the treatment of diabetic foot ulcers in a real world setting. Wound Repair Regen. 23(5), 737\u2013744 (2015).","journal-title":"Wound Repair Regen."},{"key":"e_1_3_7_38_2","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2018-0031"},{"issue":"3","key":"e_1_3_7_39_2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/wrr.12156","article-title":"Comparative effectiveness of a bilayered living cellular construct and a porcine collagen wound dressing in the treatment of venous leg ulcers","volume":"22","author":"Marston WA","year":"2014","unstructured":"Marston WA , Sabolinski ML , Parsons NB , Kirsner RS . Comparative effectiveness of a bilayered living cellular construct and a porcine collagen wound dressing in the treatment of venous leg ulcers. Wound Repair Regen. 22(3), 334\u2013340 (2014).","journal-title":"Wound Repair Regen."},{"issue":"6","key":"e_1_3_7_40_2","first-page":"1","article-title":"Expert recommendations for optimizing outcomes in the management of biofilm to promote healing of chronic wounds","volume":"28","author":"Carpenter S","year":"2016","unstructured":"Carpenter S , Davis S , Fitzgerald R Expert recommendations for optimizing outcomes in the management of biofilm to promote healing of chronic wounds. Wounds 28(Suppl. 6), 1\u201320 (2016).","journal-title":"Wounds"},{"issue":"2","key":"e_1_3_7_41_2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.12968\/jowc.2010.19.2.46966","article-title":"Chronic wounds and the medical biofilm paradigm","volume":"19","author":"Wolcott RD","year":"2010","unstructured":"Wolcott RD , Rhoads DD , Bennett ME Chronic wounds and the medical biofilm paradigm. J. Wound Care 19(2), 45\u201353 (2010).","journal-title":"J. Wound Care"},{"issue":"4","key":"e_1_3_7_42_2","doi-asserted-by":"crossref","first-page":"e1302","DOI":"10.1097\/GOX.0000000000001302","article-title":"Amnion membrane in diabetic foot wounds","volume":"5","author":"Haugh AM","year":"2017","unstructured":"Haugh AM , Witt JG , Hauch A Amnion membrane in diabetic foot wounds. Plast. Reconstr. Surg. Glob. Open 5(4), e1302 (2017).","journal-title":"Plast. Reconstr. Surg. Glob. Open"},{"issue":"8","key":"e_1_3_7_43_2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3111\/13696998.2015.1031793","article-title":"Economic outcomes among Medicare patients receiving bioengineered cellular technologies for treatment of diabetic foot ulcers","volume":"18","author":"Rice JB","year":"2015","unstructured":"Rice JB , Desai U , Ristovska L Economic outcomes among Medicare patients receiving bioengineered cellular technologies for treatment of diabetic foot ulcers. J. Med. Econ. 18(8), 586\u2013595 (2015).","journal-title":"J. Med. Econ."},{"issue":"1","key":"e_1_3_7_44_2","first-page":"10","article-title":"Wound care outcomes and associated cost among patients treated in US outpatient wound centers: data from the US Wound Registry","volume":"24","author":"Fife CE","year":"2012","unstructured":"Fife CE , Carter MJ , Walker D , Thomson B . Wound care outcomes and associated cost among patients treated in US outpatient wound centers: data from the US Wound Registry. Wounds 24(1), 10 (2012).","journal-title":"Wounds"},{"issue":"1","key":"e_1_3_7_45_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jval.2017.07.007","article-title":"An economic evaluation of the impact, cost, and medicare policy implications of chronic nonhealing wounds","volume":"21","author":"Nussbaum SR","year":"2018","unstructured":"Nussbaum SR , Carter MJ , Fife CE An economic evaluation of the impact, cost, and medicare policy implications of chronic nonhealing wounds. Value Health 21(1), 27\u201332 (2018).","journal-title":"Value Health"},{"issue":"1","key":"e_1_3_7_46_2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1001\/jamadermatol.2013.1324","article-title":"Expectations for comparative effectiveness and efficacy research: with welcomed questions may come unwelcome answers","volume":"149","author":"Eaglstein WH","year":"2013","unstructured":"Eaglstein WH , Kirsner RS . Expectations for comparative effectiveness and efficacy research: with welcomed questions may come unwelcome answers. JAMA Dermatol. 149(1), 18\u2013199 (2013).","journal-title":"JAMA Dermatol."},{"issue":"12","key":"e_1_3_7_47_2","doi-asserted-by":"crossref","first-page":"e1000194","DOI":"10.1371\/journal.pmed.1000194","article-title":"A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example","volume":"6","author":"van Staa T-P","year":"2009","unstructured":"van Staa T-P , Leufkens HG , Zhang B , Smeeth L . A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example. PLoS Med. 6(12), e1000194 (2009).","journal-title":"PLoS Med."},{"issue":"2","key":"e_1_3_7_48_2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/pds.3245","article-title":"When to randomize, or \u2018evidence-based medicine needs medicine-based evidence\u2019","volume":"21","author":"Concato J","year":"2012","unstructured":"Concato J . When to randomize, or \u2018evidence-based medicine needs medicine-based evidence\u2019. Pharmacoepidemiol. Drug Saf. 21(Suppl. 2), 6\u201312 (2012).","journal-title":"Pharmacoepidemiol. Drug Saf."}],"container-title":["Journal of Comparative Effectiveness Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/becarispublishing.com\/doi\/pdf\/10.2217\/cer-2019-0142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T12:33:15Z","timestamp":1679229195000},"score":1,"resource":{"primary":{"URL":"https:\/\/becarispublishing.com\/doi\/10.2217\/cer-2019-0142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.2217\/cer-2019-0142"],"URL":"https:\/\/doi.org\/10.2217\/cer-2019-0142","relation":{},"ISSN":["2042-6305","2042-6313"],"issn-type":[{"value":"2042-6305","type":"print"},{"value":"2042-6313","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}